BioSpace News Archive

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and MedinCell announced that the New Drug Application for TV-46000/mdc-IRM for the treatment of schizophrenia has been accepted by the U.S. Food and Drug Administration.

Sun Pharmaceutical Industries Limited today announced the expiration of the applicable waiting period under the US Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act)

Aptinyx to Participate in H.C. Wainwright 23 rd Annual Global Investment Conference

Veracyte, Inc . will participate in a fireside chat at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on Tuesday, September 14, at 3:30 p.m. Eastern Time.

Bio-Rad Laboratories, Inc. today announced that management will participate in a Fireside Chat at the 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, at 11:40 AM (Pacific Time).

Adaptive Phage Therapeutics today announced that it has entered into a licensing agreement with The Walter Reed Army Institute of Research (WRAIR) to provide APT access to the Institute’s extensive phage database.

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of new data further validating the potential of its mass cytometry technologies, including CyTOF® systems and the Maxpar® Direct™ Immune Profiling Assay™

Prospera Heart identifies rejection with exceptional performance from a single test, eliminating the need to combine two tests for each patient

Sangamo Therapeutics, Inc., a genomic medicine company, announced that management will be participating in fireside chats at the following investor conferences

The Silverstein Foundation for Parkinson’s with GBA today announced grant funding to AcureX Therapeutics to support the development of novel, first in class, small molecule drug candidates for the treatment of Parkinson’s disease (PD).